SAB Biotherapeutics Stock Performance
as on August 22, 2026 at 2:15 pm IST
Day's Low
Day's High
$3.72$3.82
1.59%
Downside
1.06%
Upside
52 Week's Low
52 Week's High
$1.85$5.1551.06%
Downside
36.24%
Upside
SAB Biotherapeutics share price movements today
- Previous Close
- $3.70
- Open
- $3.72
- Volume
- 315.0K
- Market Cap
- $336.6M
- Day's Low - High
- $3.72 - $3.82
- 52 Week Low - High
- $1.85 - $5.15
SAB Biotherapeutics Historical Returns
- 1 Month Return
- + 4.52 %
- 3 Month Return
- 0 %
- 1 Year Return
- + 66.67 %
- 3 Year Return
- -54.32 %
- 5 Year Return
- 0 %
SAB Biotherapeutics Stock Fundamentals & Key Indicators
Check SAB Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$336.6M
EPS (TTM)
1.24
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.60%
PE Ratio (TTM)
3.02
Industry PE ratio
-7.283372093023256
PEG Ratio
0.027316318214257056
EBITDA
-9.5M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-6.74%
SAB Biotherapeutics Stock Valuation
Track how SAB Biotherapeutics P/E has moved over time to understand its valuation trends.
SAB Biotherapeutics in the last 5 years
Lowest (-19.80x)
December 31, 2021
Industry (-7.28x)
December 31, 2025
Today (17.00x)
December 31, 2025
Highest (17.00x)
December 31, 2025
Today’s Price to Earnings Ratio: 17.00x
SAB Biotherapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of SAB Biotherapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $336.6M | NA | 3.02 | 0.00% | NA | |
| BUY | $43.7B | 669.3% | NA | 0.00% | NA | |
| BUY | $128.2B | 154.86% | 29.82 | 86.04% | NA | |
| BUY | $25.3B | -84.24% | -7.98 | -12.57% | NA | |
| BUY | $82.7B | 24.1% | 19.24 | 84.86% | 0.44999999999999996% |
Stock Returns calculator for SAB Biotherapeutics Stock including INR - Dollar returns
The SAB Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
SAB Biotherapeutics investment value today
Current value as on today
₹1,86,607
Returns
₹86,607
(+86.61%)
Returns from SAB Biotherapeutics Stock
₹70,270 (+70.27%)
Dollar Impact
₹16,337 (+16.34%)
Analyst Recommendation on SAB Biotherapeutics Stock
Based on 8 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for SAB Biotherapeutics. Average target price of $11.64
SAB Biotherapeutics Share Price Target
Get share price movements and forecasts by analysts on SAB Biotherapeutics.
What analysts predicted
67.53%UPSIDE
Target Price
$11.64
Current Price
$3.78
Analyzed by
8 Analysts
Target
$11.64
SAB Biotherapeutics target price $11.64, a slight upside of 67.53% compared to current price of $3.78. According to 8 analysts rating.
Indian Investors' Interest in SAB Biotherapeutics Stock
Search interest for SAB Biotherapeutics Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
SAB Biotherapeutics Quarterly Profit & Loss
All numbers in Millions USD
SAB Biotherapeutics Annual Profit & Loss
All numbers in Millions USD
SAB Biotherapeutics Quarterly Cash Flow
All numbers in Millions USD
SAB Biotherapeutics Annual Cash Flow
All numbers in Millions USD
Insights on SAB Biotherapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, SABS stock has moved up by 72.2%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, -410.0 → 114.69K (in $), with an average increase of 100.4% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 393.8%
- NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 570.7% return, outperforming this stock by 621.0%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 4 quarters, 45.44M → -22.49M (in $), with an average decrease of 56.1% per quarter
About SAB Biotherapeutics
| Organisation | SAB Biotherapeutics |
| Headquarters | 777 W 41st St., Miami Beach, FL, United States, 33140 |
| Industry | Biotechnology |
| CEO | Mr. Samuel J. Reich |
| E-voting on shares | Click here to vote |
Key Management of SAB Biotherapeutics
Name | Title |
|---|---|
Dr. Christoph Bausch M.B.A., Ph.D. | Executive VP & COO |
Dr. Alexandra Kropotova M.B.A., M.D. | Executive VP & Chief Medical Officer |
Dr. Carlos N. Carillo M.Sc., Ph.D. | Senior Vice President of Regulatory Affairs |
Mr. Samuel J. Reich | CEO & Director |
Ms. Lucy To | Executive VP & CFO |
Ms. Cristi Barnett | Vice President of Investor Relations & Corporate Communications |
Ms. Catherine DeRose | Vice President of Human Resources |
Ms. Hua Wu Ph.D. | Senior Vice President of Product Development |
Ms. Angie Parizek | Senior Vice President of Clinical Operations |
Dr. Eddie Joe Sullivan Ph.D. | Co-Founder, President & Director |
FAQs
What is SAB Biotherapeutics share price today?
SAB Biotherapeutics share price today is $3.78 as on at the close of the market. SAB Biotherapeutics share today touched a day high of $3.82 and a low of $3.72.
What is the 52 week high and 52 week low for SAB Biotherapeutics share?
SAB Biotherapeutics share touched a 52 week high of $5.15 on and a 52 week low of $1.85 on . SAB Biotherapeutics stock price today i.e. is closed at $3.78,which is 26.60% down from its 52 week high and 104.32% up from its 52 week low.
What is SAB Biotherapeutics's market capitalisation today?
SAB Biotherapeutics market capitalisation is $0.00T as on .
How to invest in SAB Biotherapeutics Stock (SABS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for SAB Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in SAB Biotherapeutics Shares that will get you 0.3968 shares as per SAB Biotherapeutics share price of $3.78 per share as on August 22, 2026 at 8:45 am IST.
What is the minimum amount required to buy SAB Biotherapeutics Stock (SABS) from India?
Indian investors can start investing in SAB Biotherapeutics (SABS) shares with as little as ₹95.71 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.10 in SAB Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on SAB Biotherapeutics share’s latest price of $3.78 as on August 22, 2026 at 8:45 am IST, you will get 2.6455 shares of SAB Biotherapeutics. Learn more about
fractional shares .